Detalhe da pesquisa
1.
FoxO1 is required for physiological cardiac hypertrophy induced by exercise but not by constitutively active PI3K.
Am J Physiol Heart Circ Physiol
; 320(4): H1470-H1485, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33577435
2.
Distinct lipidomic profiles in models of physiological and pathological cardiac remodeling, and potential therapeutic strategies.
Biochim Biophys Acta Mol Cell Biol Lipids
; 1863(3): 219-234, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217479
3.
Gene delivery of medium chain acyl-coenzyme A dehydrogenase induces physiological cardiac hypertrophy and protects against pathological remodelling.
Clin Sci (Lond)
; 132(3): 381-397, 2018 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29358507
4.
Sex differences in response to miRNA-34a therapy in mouse models of cardiac disease: identification of sex-, disease- and treatment-regulated miRNAs.
J Physiol
; 594(20): 5959-5974, 2016 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27270487
5.
Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy.
FASEB J
; 28(12): 5097-110, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25145628
6.
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets.
Arch Toxicol
; 89(9): 1401-38, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25708889
7.
Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function.
Proc Natl Acad Sci U S A
; 109(43): 17615-20, 2012 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23047694
8.
Novel Lipid Species for Detecting and Predicting Atrial Fibrillation in Patients With Type 2 Diabetes.
Diabetes
; 70(1): 255-261, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33115826
9.
Lipidomic Profiles of the Heart and Circulation in Response to Exercise versus Cardiac Pathology: A Resource of Potential Biomarkers and Drug Targets.
Cell Rep
; 24(10): 2757-2772, 2018 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30184508
10.
Inhibition of miR-154 Protects Against Cardiac Dysfunction and Fibrosis in a Mouse Model of Pressure Overload.
Sci Rep
; 6: 22442, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26928825
11.
Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy.
PLoS One
; 9(2): e90337, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24587330
12.
The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice.
Nat Commun
; 5: 5705, 2014 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25489988
13.
Phosphoinositide 3-kinase p110α is a master regulator of exercise-induced cardioprotection and PI3K gene therapy rescues cardiac dysfunction.
Circ Heart Fail
; 5(4): 523-34, 2012 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22705768